home > 전문가 컨설팅> 온라인 컨설팅서비스> 컨설팅 신청
프린트
전체 256건, 현재 페이지 3/26
GPKOL
인허가 기술마케팅 GMP
R & D기획 기술마케팅
Derek Yoon As President & CEO, Mr. Yoon leads Solasta Ventures (formerly known as Aju IB Investment), one of the leading venture capital firms in South Korea. Based in Boston, Massachusetts, Mr. Yoon oversees Solasta’s investments with a focus on U.S. based life science companies and early stage start-ups with novel science. Mr. Yoon also leads multiple cross-border strategic partnerships by leveraging his relationship with top-tier pharmaceutical companies in Korea. Currently, he is involved in multiple overseas venture capital fundraising projects by interacting with Korean governmental institutional funds as well as various private investors in Asia. Additionally, Mr. Yoon is a board member of Arcellx (Nasdaq: ACLX), Carbon Biosciences, EvolveImmune Therapeutics, and Trefoil Therapeutics, and a board observer at various private biotechnology companies. Prior to Solasta Ventures, he spent more than twenty years in alternative (VC/PE) investments and healthcare corporate banking where he took numerous responsibilities in portfolio management, deal structuring, and fundraising. His previous experience includes venture investment management at Kibo Capital, the first venture fund in Korea; portfolio management with RBS Healthcare Banking Group; and venture accelerator program at Berwind Private Equity, a multi-generational family office located in Harvard, Massachusetts. Mr. Yoon earned his M.B.A. from Babson College, M.S.F. from Boston College and B.S. in Chemical Engineering from Yonsei University in Seoul, Korea.
기술마케팅
- BD&L, M&A and Market Access in Russia and CIS
R & D기획 임상 PM 인허가 기술마케팅 GMP
인도
~ Well-differentiated formulation Development ~ Pharmaceutical New Product Development strategies ~ Patent Non-Infringing formulation and process development ~ Conceptualization/Ideation, Feasibility Studies ~ Competitive Intelligence and Investment De-Risking Strategies ~ CMC /CTD/ eCTD Development and review ~ IMPD/IND/NCE opportunities - 505(b)(1) products ~ NDA opportunities - 505 (b)(2) products ~ ANDA - 505 (j), First-To-File Products & Paragraph IV product opportunities ~ Novel Drug Delivery Systems - NDDS Products ~ Proprietary Formulations and Platform Technologies Development ~ Unmet Medical Needs Assessment ~ Real-World-Examples and Commercial Assessment ~ Product Life-Cycle-Management (LCM) Strategies ~ Health Economics and Outcomes Research (HEOR) Analysis ~ Product Portfolio building ~ Rare/Orphan Drug Development opportunities ~ Revival of "Dead Clinical Assets” by applying Multi-Disciplinary Technological Approaches ~ Managing Teams of Multidisciplinary Scientists ~ Product Development Budgeting, Timelines and Project Management ~ Scale-Up, Validations and Technology Transfer ~ KOL Profiling & Engagement as per product requirements ~ Clinical Supplies, CRO, and CDMO Engagement
기술마케팅 PM
중국
BD, strategic planning, MKT, and sales management in China
기술마케팅 임상 R & D기획 PM
미국
Strategic Partnerships / Business Development / Alliances & Integration Relationship Management / Clinical Operations / Healthcare Systems
기술마케팅 임상 R & D기획
스위스
- 유럽지역 사업개발 컨설팅
- 터키, 중동, 북아프리카(MENA)지역 시장 진출
GMP 인허가 PM
